Literature DB >> 16619485

Selenium protection from DNA damage involves a Ref1/p53/Brca1 protein complex.

Joshua L Fischer1, Jody K Lancia, Anita Mathur, Martin L Smith.   

Abstract

Selenium, in the form of seleno-L-methionine (SeMet), induced Redox-factor-1 (Ref1) and p53 proteins in normal human and mouse fibroblasts. Ref1 and p53 are known to be associated with each other, resulting in enhanced sequence-specific DNA binding by p53 and transactivation of p53-regulated effector genes. SeMet preferentially induced the DNA repair branch of the p53 pathway, while apoptosis and cell cycle arrest were unaffected. Accordingly, pretreatment with SeMet protected normal fibroblasts from subsequent DNA damage. In the current study, Brca1 and Ref1 were shown to interact concurrently with p53 in targeting a SeMet-induced DNA repair response. Moreover, like p53 and Ref1, Brca1 was required for SeMet-mediated DNA damage protection, as brca1 -/- mouse fibroblasts were not protected from UV-radiation by SeMet treatment. These findings indicate that besides p53 and Ref1, Brca1 is required for selenium protection from DNA damage. The data are consistent with selective induction of the DNA repair branch of the p53 pathway by SeMet.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16619485

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  26 in total

1.  Low doses of selenium specifically stimulate the repair of oxidative DNA damage in LNCaP prostate cancer cells.

Authors:  Viviana de Rosa; Pinar Erkekoğlu; Anne Forestier; Alain Favier; Filiz Hincal; Alan M Diamond; Thierry Douki; Walid Rachidi
Journal:  Free Radic Res       Date:  2012-01-25

2.  Biological Effects of Space Radiation and Development of Effective Countermeasures.

Authors:  Ann R Kennedy
Journal:  Life Sci Space Res (Amst)       Date:  2014-04-01

3.  Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck.

Authors:  Michael Mix; Anurag K Singh; Michael Tills; Shiva Dibaj; Adrienne Groman; Wainwright Jaggernauth; Youcef Rustum; Michael B Jameson
Journal:  World J Clin Oncol       Date:  2015-10-10

4.  Effects of selenomethionine on acute toxicities from concurrent chemoradiation for inoperable stage III non-small cell lung cancer.

Authors:  Michael Mix; Nithya Ramnath; Jorge Gomez; Charles de Groot; Saju Rajan; Shiva Dibaj; Wei Tan; Youcef Rustum; Michael B Jameson; Anurag K Singh
Journal:  World J Clin Oncol       Date:  2015-10-10

5.  Overexpression of Ref-1 Inhibits Lead-induced Endothelial Cell Death via the Upregulation of Catalase.

Authors:  Kwon Ho Lee; Sang Ki Lee; Hyo Shin Kim; Eun Jung Cho; Hee Kyoung Joo; Eun Ji Lee; Ji Young Lee; Myoung Soo Park; Seok Jong Chang; Chung-Hyun Cho; Jin Bong Park; Byeong Hwa Jeon
Journal:  Korean J Physiol Pharmacol       Date:  2009-12-31       Impact factor: 2.016

Review 6.  Versatile functions of p53 protein in multicellular organisms.

Authors:  P M Chumakov
Journal:  Biochemistry (Mosc)       Date:  2007-12       Impact factor: 2.487

Review 7.  Molecular mechanisms by which selenoproteins affect cancer risk and progression.

Authors:  Pin Zhuo; Alan M Diamond
Journal:  Biochim Biophys Acta       Date:  2009-03-13

Review 8.  Redox regulation of DNA repair: implications for human health and cancer therapeutic development.

Authors:  Meihua Luo; Hongzhen He; Mark R Kelley; Millie M Georgiadis
Journal:  Antioxid Redox Signal       Date:  2010-06-01       Impact factor: 8.401

Review 9.  Does a role for selenium in DNA damage repair explain apparent controversies in its use in chemoprevention?

Authors:  Soumen Bera; Viviana De Rosa; Walid Rachidi; Alan M Diamond
Journal:  Mutagenesis       Date:  2012-11-30       Impact factor: 3.000

10.  High-dose selenium for the mitigation of radiation injury: a pilot study in a rat model.

Authors:  Fritz Sieber; Sarah A Muir; Eric P Cohen; Paula E North; Brian L Fish; Amy A Irving; Marylou Mäder; John E Moulder
Journal:  Radiat Res       Date:  2009-03       Impact factor: 2.841

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.